Replication of M13 single-stranded viral DNA bearing single site-specific adducts by escherichia coli cell extracts: differential efficiency of translesion DNA synthesis for SOS-dependent and SOS-independent lesions
- PMID: 9235993
- DOI: 10.1021/bi970650o
Replication of M13 single-stranded viral DNA bearing single site-specific adducts by escherichia coli cell extracts: differential efficiency of translesion DNA synthesis for SOS-dependent and SOS-independent lesions
Abstract
In order to characterize mutagenic translesion DNA synthesis in UVM-induced Escherichia coli, we have developed a high-resolution DNA replication system based on E. coli cell extracts and M13 genomic DNA templates bearing mutagenic lesions. The assay is based on the conversion of M13 viral single-stranded DNA (ssDNA) bearing a single site-specific DNA lesion to the double-stranded replicative form (RF) DNA, and permits one to quantitatively measure the efficiency of translesion synthesis. Our data indicate that DNA replication is most strongly inhibited by an abasic site, a classic SOS-dependent noninstructive lesion. In contrast, the efficiency of translesion synthesis across SOS-independent lesions such as O6-methylguanine and DNA uracil is around 90%, very close to the values obtained for control DNA templates. The efficiency of translesion synthesis across 3,N4-ethenocytosine and 1, N6-ethenoadenine is around 20%, a value that is similar to the in vivo efficiency deduced from the effect of the lesions on the survival of transfected M13 ssDNA. Neither DNA polymerase I nor polymerase II appears to be required for the observed translesion DNA synthesis because essentially similar results are obtained with extracts from polA- or polB-defective cells. The close parallels in the efficiency of translesion DNA synthesis in vitro and in vivo for the five site-specific lesions included in this study suggest that the assay may be suitable for modeling mutagenesis in an accessible in vitro environment.
Similar articles
-
Replication of M13 single-stranded DNA bearing a site-specific ethenocytosine lesion by Escherichia coil cell extracts.Cell Res. 1997 Jun;7(1):1-12. doi: 10.1038/cr.1997.1. Cell Res. 1997. PMID: 9261557
-
Escherichia coli DNA polymerase II can efficiently bypass 3,N(4)-ethenocytosine lesions in vitro and in vivo.Mutat Res. 2006 Jan 29;593(1-2):164-76. doi: 10.1016/j.mrfmmm.2005.07.016. Epub 2005 Sep 19. Mutat Res. 2006. PMID: 16171831
-
The Escherichia coli UVM response is accompanied by an SOS-independent error-prone DNA replication activity demonstrable in vitro.Mol Microbiol. 2000 Oct;38(2):368-80. doi: 10.1046/j.1365-2958.2000.02136.x. Mol Microbiol. 2000. PMID: 11069662
-
Translesion synthesis in Escherichia coli: lessons from the NarI mutation hot spot.DNA Repair (Amst). 2007 Jul 1;6(7):1032-41. doi: 10.1016/j.dnarep.2007.02.021. Epub 2007 Apr 2. DNA Repair (Amst). 2007. PMID: 17403618 Review.
-
Postreplication repair mechanisms in the presence of DNA adducts in Escherichia coli.Mutat Res. 2011 May-Jun;727(3):104-22. doi: 10.1016/j.mrrev.2011.04.003. Epub 2011 May 5. Mutat Res. 2011. PMID: 21558018 Review.
Cited by
-
SOS and UVM pathways have lesion-specific additive and competing effects on mutation fixation at replication-blocking DNA lesions.J Bacteriol. 1999 Mar;181(5):1515-23. doi: 10.1128/JB.181.5.1515-1523.1999. J Bacteriol. 1999. PMID: 10049383 Free PMC article.
-
The interplay at the replisome mitigates the impact of oxidative damage on the genetic integrity of hyperthermophilic Archaea.Elife. 2019 Jun 11;8:e45320. doi: 10.7554/eLife.45320. Elife. 2019. PMID: 31184586 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources